|
Market Closed -
NSE India S.E.
07:05:10 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 1,864.90 INR | -1.11% |
|
-3.32% | +8.44% |
| 09-09 | Sun Pharma Sets Up Global Treasury Center in India's GIFT City | MT |
| 09-08 | Sun Pharma Assigned Baa1, BBB+ Ratings by Moody's, S&P | MT |
Company Valuation: Sun Pharmaceutical Industries Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,194,737 | 2,358,729 | 3,888,242 | 4,162,126 | 4,216,111 | 4,474,520 | - | - |
| Change | - | 7.47% | 64.84% | 7.04% | 1.3% | 6.13% | - | - |
| Enterprise Value (EV) 1 | 2,077,371 | 2,269,278 | 3,725,634 | 3,930,920 | 3,931,562 | 4,203,855 | 4,136,101 | 4,041,826 |
| Change | - | 9.24% | 64.18% | 5.51% | 0.02% | 6.93% | -1.61% | -2.28% |
| P/E | 67.3x | 27.8x | 40.6x | 38x | 36.8x | 34.4x | 29.1x | 25.1x |
| PBR | 4.57x | 4.21x | 6.11x | 5.76x | 5.04x | 4.82x | 4.31x | 3.85x |
| PEG | - | 0x | 3.1x | 2.7x | 7.63x | 2.6x | 1.6x | 1.6x |
| Capitalization / Revenue | 5.68x | 5.37x | 8.02x | 7.92x | 7.21x | 6.87x | 6.14x | 5.53x |
| EV / Revenue | 5.37x | 5.17x | 7.68x | 7.48x | 6.72x | 6.46x | 5.67x | 4.99x |
| EV / EBITDA | 20x | 19.5x | 28.7x | 26.1x | 23.8x | 22.4x | 19x | 16.2x |
| EV / EBIT | 25.2x | 24.9x | 35.7x | 31.4x | 29x | 27.1x | 22.8x | 18.9x |
| EV / FCF | 27.7x | 79x | 37.5x | 32.9x | 44.6x | 71.6x | 30.8x | 26.7x |
| FCF Yield | 3.61% | 1.27% | 2.67% | 3.04% | 2.24% | 1.4% | 3.25% | 3.74% |
| Dividend per Share 2 | 10 | 11.5 | 13.5 | 16 | 16 | 17.09 | 19.86 | 21.09 |
| Rate of return | 1.09% | 1.17% | 0.83% | 0.92% | 0.91% | 0.92% | 1.07% | 1.13% |
| EPS 2 | 13.6 | 35.3 | 39.9 | 45.6 | 47.8 | 54.2 | 64 | 74.29 |
| Distribution rate | 73.5% | 32.6% | 33.8% | 35.1% | 33.5% | 31.5% | 31% | 28.4% |
| Net sales 1 | 386,545 | 438,857 | 484,968 | 525,784 | 584,620 | 651,013 | 729,020 | 809,703 |
| EBITDA 1 | 103,977 | 116,468 | 129,870 | 150,862 | 164,912 | 187,903 | 217,622 | 249,612 |
| EBIT 1 | 82,540 | 91,174 | 104,304 | 125,108 | 135,534 | 155,287 | 181,351 | 213,600 |
| Net income 1 | 32,727 | 84,736 | 95,764 | 109,290 | 114,794 | 129,664 | 153,643 | 179,216 |
| Net Debt 1 | -117,366 | -89,450 | -162,609 | -231,206 | -284,549 | -270,664 | -338,418 | -432,694 |
| Reference price 2 | 914.75 | 983.10 | 1,620.55 | 1,734.70 | 1,757.20 | 1,864.90 | 1,864.90 | 1,864.90 |
| Nbr of stocks (in thousands) | 2,399,276 | 2,399,276 | 2,399,335 | 2,399,335 | 2,399,335 | 2,399,335 | - | - |
| Announcement Date | 5/30/22 | 5/26/23 | 5/22/24 | 5/22/25 | 5/22/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.8x | 6.53x | 22.64x | 0.91% | 47.73B | |
| 16.93x | 2.1x | 9.31x | 1.52% | 40.21B | |
| 27.47x | 3.92x | 16.25x | 0.59% | 12.05B | |
| 26.94x | 3.27x | 16.92x | 0.94% | 11.79B | |
| 18.73x | 3.33x | 11.58x | 3.85% | 9.16B | |
| 9.21x | 2.11x | 5.46x | 4.7% | 7.34B | |
| 15.64x | 2.05x | 6.8x | 3.23% | 7.39B | |
| 30.1x | 3.94x | 18.33x | 0.15% | 7.37B | |
| 35.63x | 6.96x | 25.4x | 0.93% | 4.72B | |
| Average | 23.94x | 3.80x | 14.74x | 1.87% | 16.42B | |
| Weighted average by Cap. | 25.28x | 4.09x | 15.58x | 1.5% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SUNPHARMA Stock
- Valuation Sun Pharmaceutical Industries Ltd.
Select your edition
All financial news and data tailored to specific country editions
